SEB Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
SEB Asset Management's BMY Position: Q2 2026 in Review
SEB Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, selling an estimated $41M and leaving 2,872,632 shares worth $166M. The position accounts for 0.62% of the portfolio, ranked #26.
SEB Asset Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $218M in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- SEB Asset Management held 2,872,632 shares of Bristol-Myers Squibb worth $166M as of Q2 2026.
- SEB Asset Management sold 713,733 Bristol-Myers Squibb shares in Q2 2026, an estimated $41M.
- Bristol-Myers Squibb made up 0.62% of SEB Asset Management's portfolio in Q2 2026, its #26 holding.
- SEB Asset Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- SEB Asset Management's Bristol-Myers Squibb position peaked at $218M in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.